Frontiers In Immunology

Frontiers In Immunology

免疫学前沿

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Frontiers In Immunology》是由Frontiers Media S.A.出版社于2010年创办的英文国际期刊(ISSN: 1664-3224,E-ISSN: 1664-3224),该期刊长期致力于免疫学领域的创新研究,主要研究方向为IMMUNOLOGY。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表免疫学领域等方向的原创性研究为核心(研究类文章占比71.28%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在5971篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Frontiers In Immunology审稿周期约为 14 Weeks 。该刊近年未被列入国际预警名单,年发文量约5971篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 5971 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 38 / 181

79.3%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 43 / 181

76.52%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.8 SJR:1.868 SNIP:1.193
学科类别 分区 排名 百分位
大类:Medicine 小类:Immunology and Allergy Q1 52 / 233

77%

大类:Medicine 小类:Immunology Q1 58 / 236

75%

期刊发文

  • Serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis

    Author: Zhu, Youwen; Liu, Kun; Qin, Qun; Zhu, Hong

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1044678

  • Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China

    Author: Zhao, Dan-Tong; Yan, Hui-Ping; Liao, Hui-Yu; Liu, Yan-Min; Han, Ying; Zhang, Hai-Ping; Zhang, Wei-Ming; Huang, Chun-Yang; Liu, Xiu-Hong; Lou, Jin-Li; Zhao, Yan

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1098076

  • The altered metabolites contributed by dysbiosis of gut microbiota are associated with microbial translocation and immune activation during HIV infection

    Author: Zhang, Yu; Xie, Zhiman; Zhou, Jie; Li, Yanjun; Ning, Chuanyi; Su, Qisi; Ye, Li; Ai, Sufang; Lai, Jingzhen; Pan, Peijiang; Liu, Ningmei; Liao, Yanyan; Su, Qijian; Li, Zhuoxin; Liang, Hao; Cui, Ping; Huang, Jiegang

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1020822

  • Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection

    Author: Zhang, Lu; Jiang, Tingting; Yang, Ying; Deng, Wen; Lu, Huihui; Wang, Shiyu; Liu, Ruyu; Chang, Min; Wu, Shuling; Gao, Yuanjiao; Hao, Hongxiao; Shen, Ge; Xu, Mengjiao; Chen, Xiaoxue; Hu, Leiping; Yang, Liu; Bi, Xiaoyue; Lin, Yanjie; Lu, Yao; Jiang, Yuyong; Li, Minghui; Xie, Yao

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1112234

  • Depressive symptoms predict longitudinal changes of chronic inflammation at the transition to adulthood

    Author: Zhai, Shuang; Qu, Yang; Zhang, Dan; Li, Tingting; Xie, Yang; Wu, Xiaoyan; Zou, Liwei; Yang, Yajuan; Tao, Fangbiao; Tao, Shuman

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1036739

  • Granulocytic myeloid-derived suppressor cells increase infection risk via the IDO/IL-10 pathway in patients with hepatitis B virus-related liver failure

    Author: Yu, Xueping; Sun, Jian; Yang, Feifei; Mao, Richeng; Shen, Zhiqing; Ren, Lan; Yuan, Songhua; He, Qian; Zhang, Linxia; Yang, Yu; Ding, Xiangqing; He, Yongquan; Zhu, Haoxiang; Shen, Zhongliang; Zhu, Mengqi; Qiu, Chao; Su, Zhijun; Zhang, Jiming

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.966514

  • Combination of transcriptional biomarkers and clinical parameters for early prediction of sepsis indued acute respiratory distress syndrome

    Author: Yao, Ren-Qi; Shen, Zong; Ma, Qi-Min; Ling, Ping; Wei, Chen-Ru; Zheng, Li-Yu; Duan, Yu; Li, Wei; Zhu, Feng; Sun, Yu; Wu, Guo-Sheng

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1084568

  • m6A eraser FTO modulates autophagy by targeting SQSTM1/P62 in the prevention of canagliflozin against renal fibrosis

    Author: Yang, Youjing; Li, Qianmin; Ling, Yi; Leng, Linxin; Ma, Yu; Xue, Lian; Lu, Guoyuan; Ding, Yue; Li, Jianzhong; Tao, Shasha

    Journal: FRONTIERS IN IMMUNOLOGY. 2023; Vol. 13, Issue , pp. -. DOI: 10.3389/fimmu.2022.1094556